SIMPSON, E.; MEROLA, J.; SILVERBERG, J.; ZACHARIAE, R.; OLSEN, R.; WOLLENBERG, A. Safety of Specifically Targeting Interleukin 13 with Tralokinumab in Adult Patients with Moderate-To-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-Blind, Placebo-Controlled Phase 3 and Phase 2 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s11, 2021. DOI: 10.25251/skin.5.supp.11. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1164. Acesso em: 4 jul. 2024.